Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypoxic Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06831071
What this trial is testing

Evaluation of Hypoxia in Primary Melanoma

Who this might be right for
Melanoma
Yana Najjar 50
Post-approval studies (Phase 4)Looking for participantsNCT07395596
What this trial is testing

Remimazolam for Bronchoscopy in High-Risk Patients

Who this might be right for
Pulmonary InfectionPulmonary NodulePhthisis+2 more
First Affiliated Hospital of Zhejiang University 360
Not applicableUnknownNCT04629079
What this trial is testing

Improving the Early Detection of Lung Cancer by Combining Exosomal Analysis of Hypoxia With Standard of Care Imaging

Who this might be right for
Lung Cancer
King's College London 800
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07618793
What this trial is testing

Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma

Who this might be right for
Lung Squamous Cell CarcinomaCarcinoma, Non-Small-Cell Lung (NSCLC)
zhang yi 60
Early research (Phase 1)Active Not RecruitingNCT05030506
What this trial is testing

Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 45
Not applicableWithdrawnNCT05904704
What this trial is testing

Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial Tumors

Who this might be right for
Intracranial Neoplasm
OHSU Knight Cancer Institute
Not applicableStudy completedNCT01567800
What this trial is testing

Prostate Hypoxia FAZA

Who this might be right for
Prostate Cancer
University Health Network, Toronto 18
Not applicableEnded earlyNCT01613521
What this trial is testing

Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer

Who this might be right for
Cervical Cancer
Memorial Sloan Kettering Cancer Center 3
Not applicableUnknownNCT03373994
What this trial is testing

Perfusion and Hypoxia Evaluation in Tumors Using 18F-FDG PET/CT

Who this might be right for
Perfusion and Hypoxia
Harbin Medical University 40
Not applicableStudy completedNCT00574353
What this trial is testing

Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 23
Not applicableNot Yet RecruitingNCT07563075
What this trial is testing

Effect of High-Flow Nasal Cannula Oxygen Therapy on Hypoxemia in Pediatric Sedated Bronchoscopy

Who this might be right for
HypoxemiaPneumoniaPulmonary Neoplasm
Zhejiang University 430
Testing effectiveness (Phase 2)Ended earlyNCT00771381
What this trial is testing

Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer

Who this might be right for
Breast Neoplasm
AHS Cancer Control Alberta 23
Not applicableStudy completedNCT02016872
What this trial is testing

Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients

Who this might be right for
Non-Small-Cell-Lung Cancer (NSCLC)
Memorial Sloan Kettering Cancer Center 25
Not applicableUnknownNCT06433063
What this trial is testing

Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA Treatment

Who this might be right for
Prostatic NeoplasmsHypoxia
Cigdem Soydal 30
Not applicableLooking for participantsNCT04467333
What this trial is testing

Giessen Pulmonary Hypertension in Lung Cancer Registry

Who this might be right for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
University of Giessen 500
Not applicableLooking for participantsNCT05393492
What this trial is testing

Regulating Emotions and Behaviors After Brain Injury

Who this might be right for
Acquired Brain InjuryStroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic)Brain Tumor (After Recovery)+3 more
University Hospital, Strasbourg, France 77
Not applicableUnknownNCT02352792
What this trial is testing

Hypoxia-based Dose Escalation With Radiochemotherapy in Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University Hospital Tuebingen 90
Testing effectiveness (Phase 2)Study completedNCT00743379
What this trial is testing

Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerProstate CancerPancreatic Cancer
Threshold Pharmaceuticals 71
Testing effectiveness (Phase 2)Study completedNCT02695628
What this trial is testing

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Who this might be right for
Adult Liver CarcinomaLiver Cirrhosis
Stanford University 5
Not applicableEnrolling By InvitationNCT07617038
What this trial is testing

OE MRI to Predict Treatment Response After TACE in HCC Patients

Who this might be right for
HCC - Hepatocellular CarcinomaTACESIRT
Université de Montréal 60
Next Page